Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study.

Autor: Coppola, Antonio1 (AUTHOR) acoppoladoc@gmail.com, Rivolta, Gianna Franca1 (AUTHOR) gquintavalle@ao.pr.it, Quintavalle, Gabriele1 (AUTHOR) amatichecchia@ao.pr.it, Matichecchia, Annalisa1 (AUTHOR) friccardi@ao.pr.it, Riccardi, Federica1 (AUTHOR) atagliaferri@ao.pr.it, Rossi, Rossana2 (AUTHOR) rorossi@ao.pr.it, Benegiamo, Anna2 (AUTHOR) abenegiamo@ao.pr.it, Ranalli, Paola3 (AUTHOR) paola.ranalli@asl.pe.it, Coluccio, Valeria4 (AUTHOR) coluccio.valeria@aou.mo.it, Tagliaferri, Annarita1 (AUTHOR)
Zdroj: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 5, p1518. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje